Clinical Trials in Florida

Showing 6921-6940 of 9,710 trials

TR(ACE) Assay Clinical Specimen Study

NCT02934360

The TR(ACE) Assay is a quantitative in vitro diagnostic test run on the TR(ACE) Instrument intended for the measurement of high molecular weight human DNA from plasma as an aid to monitoring disease progression or response to therapy or recurrent or residual disease.

Carcinoma, Non-Small-Cell LungBreast Neoplasms

Biological Dynamics450 participantsStarted Sep 2016

Encinitas, California, United States • Oceanside, California, United States • Santa Monica, California, United States +13 more locations

COMPLETEDPhase 336 miles

Asthma Exacerbation Study

NCT01086384

This study will establish the safety as well as demonstrate benefit of the addition of a LABA to an ICS by utilizing an endpoint (time to first severe asthma exacerbation) that informs on both safety and efficacy.

Asthma

GlaxoSmithKline2,020 participantsStarted Feb 2010

Birmingham, Alabama, United States • Mobile, Alabama, United States • Oxford, Alabama, United States +180 more locations

TR(ACE) Assay Clinical Specimen Study

Asthma Exacerbation Study

Find Trials by Condition in Florida

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

Epic Allies HIV ART Adherence Intervention

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease